Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Arcturus Therapeutics Holdings Inc shares valued at $1,601,500 were sold by SASSINE ANDY on Jun 12 ’24. At $32.03 per share, SASSINE ANDY sold 50,000 shares. The insider’s holdings dropped to 220,526 shares worth approximately $5.86 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Chivukula Pad sold 114 shares, netting a total of over 5,130 in proceeds. Following the sale of shares at $45.00 each, the insider now holds 447,334 shares.
Before that, Chivukula Pad had sold 26,000 shares from its account. In a trade valued at $1,040,234, the Chief Scientific Officer & COO traded Arcturus Therapeutics Holdings Inc shares for $40.01 each. Upon closing the transaction, the insider’s holdings decreased to 26,000 shares, worth approximately $11.9 million.
As published in their initiating research note from Canaccord Genuity on December 13, 2023, Arcturus Therapeutics Holdings Inc [ARCT] has been a Buy and the price target has been revised to $90. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late July. As of May 11, 2023, H.C. Wainwright has increased its “Neutral” rating to a “Buy” for ARCT.
Analyzing ARCT Stock Performance
During the last five days, there has been a drop of approximately -14.39%. Over the course of the year, Arcturus Therapeutics Holdings Inc shares have dropped approximately -15.67%. Shares of the company reached a 52-week high of $45.00 on 06/05/24 and a 52-week low of $25.20 on 06/20/24. A 50-day SMA is recorded $30.66, while a 200-day SMA reached $29.78. Nevertheless, trading volume fell to 1.82 million shares from 0.76 million shares the previous day.
Support And Resistance Levels for Arcturus Therapeutics Holdings Inc (ARCT)
According to the 24-hour chart, there is a support level at 25.64, which, if violated, would cause prices to drop to 24.70. In the upper region, resistance lies at 27.09. The next price resistance is at 27.60. RSI (Relative Strength Index) is 37.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -7.27, which suggests the price will decrease in the coming days. Percent R is at 92.98%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
